Company profile
Protara Therapeutics, Inc. Insider Trading
TARAEvery SEC Form 4 insider trading filing for Protara Therapeutics, Inc. (TARA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001359931
- Filings
- 98
- Insiders
- 16
- Last filing
- 2026-06-30
Activity summary
No insider transactions in the last 30 days. The most recent was on June 30, 2026, when Jesse Shefferman sold 14,000 shares. 98 filings from 16 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Protara Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.1M.
90 day insight
Over the last 90 days, Protara Therapeutics, Inc. insiders bought $412K (2 transactions) and sold $882K (1 transaction).
- Most active insider: Jesse Shefferman with 7 transactions totaling $1.3M.
- Largest single sale: $882K by Jesse Shefferman on Jun 29, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jesse Shefferman | TARA | Gift | 14,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman | TARA | Gift | 7,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman | TARA | Gift | 4,000 | — | — |
| Jun 30, 2026 | Jesse Shefferman | TARA | Gift | 5,000 | — | — |
| Jun 29, 2026 | Jesse Shefferman | TARA | Option Exercise | 215,687 | $1.91 | $412K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TARA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Protara Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →